首頁 > 市場調查報告書 > 製藥

生技設備生物工藝

歐洲生物製程技術市場預測至 2028 年 - 按類型、模式和最終用戶進行的區域分析

市場調查報告書

商品編碼

1375206

歐洲生物製程技術市場預測至 2028 年 - 按類型、模式和最終用戶進行的區域分析

Europe Bioprocess Technology Market Forecast to 2028 - Regional Analysis By Type, Modality, and End User

出版日期: 2023年09月14日 | 出版商:

The Insight Partners | 英文 143 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

歐洲生物製程技術市場預計將從2023年的122.9088億美元成長到2028年的265.8836億美元。預計2023年至2028年年複合成長率為16.7%。

引進先進的生物製程技術推動歐洲生物製程技術市場

先進的生物製程技術將研發與生產連結起來。一些參與者正在市場上引入各種新的生物加工技術。 2020 年 12 月 4 日，IDBS（生物技術和製藥行業軟體資訊學解決方案提供商）宣布推出 Polar。 Polar 創建了一個名為生物製藥生命週期管理 (BPLM) 的新產品類別，以簡化生物製藥研究中的藥物開發和生產。 Polar 的設計和部署旨在快速解決與工作流程、流程品質、協作和資料分析相關的挑戰，這些挑戰一直困擾著現有的軟體解決方案，包括實驗室資訊管理系統(LIMS) 和電子實驗室筆記本(ELN)。因此，人為錯誤將會減少，整體準確度也會提高。它將減少手動資料處理和轉錄，從而減少人為錯誤並提高整體準確性。它還具有廣泛的搜尋功能，使用戶可以更輕鬆地找到他們正在搜尋的內容，從而避免無意義的重複工作。

梅特勒-托利多的 Dynochem Biologics 是一款專用模擬軟體，支援任何規模的生物加工中的上游和下游單元活動。生物製程工程師和科學家使用該軟體選擇適當的製程操作參數並建立等效規模。實用程式可以用最少的資料快速評估設備性能，而更有效的模型則利用現有的資料流進行製程表徵。透過快速回應的應用專業知識、豐富的培訓資源和已建置的模型庫，可以快速完成初始專案。勝肽、單株抗體、疫苗接種和病毒載體只是眾多應用中的幾個例子。

默克的全新 BioContinuum 平台透過提高效率、簡化工廠運作以及更高的品質和一致性來推進生物治療藥物的生產。此外，默克的 Pellicon 單通道切向流過濾有助於強化與治療性蛋白質純化相關的操作。因此，各種新時代生物程序技術的引入可能會在預測期內為市場成長提供利潤豐厚的機會。

歐洲生物程序技術市場概況

據德國貿易投資總署稱，該國是第二大醫藥產品出口國，並躋身全球頂級醫藥生產國之列。由於個人化醫療需求的不斷成長，德國也已發展成為新型生物製藥的主要供應國之一。生物製劑因其高治療潛力而在德國醫藥市場佔有相當大的佔有率。根據德國貿易投資總署（GTAI）的報告，2015年至2019年，生物製劑市場年均成長11.6%（是整個製藥市場成長的兩倍多）。 2019年德國生物製藥總收入為139.6億美元，相當於醫藥市場的四分之一以上。德國擁有歐洲主要的醫藥市場，也是全球第四大醫藥市場。 2019年，德國製藥業銷售額較2018年成長5.7%，達510.1億美元（出廠價）。德國有超過 500 家製藥公司。中小企業是經濟部門的支柱，約 90% 的藥廠員工人數不到 500 人。因此，歐洲不斷成長的製藥市場將推動生物製程技術的使用，因為生物技術有助於製藥公司開發新產品、製程、方法和服務並改進現有產品、製程、方法和服務。

歐洲生物程序技術市場收入及 2028 年預測（百萬美元）

歐洲生物程序技術市場細分

歐洲生物程序技術市場按類型、模式、最終用戶和國家進行細分。

根據類型，歐洲生物製程技術市場分為細胞培養基生物製程、色譜生物製程以及消耗品和配件等。 2023年，消耗品和配件領域在歐洲生物製程技術市場中佔據最大佔有率。

根據模式，歐洲生物加工技術市場分為一次性使用和多次使用。 2023年，一次性使用領域在歐洲生物製程技術市場中佔有更大佔有率。

根據最終用戶，歐洲生物製程技術市場分為學術和醫療機構、生物製藥公司、研究實驗室等。 2023年，生物製藥公司領域在歐洲生物製程技術市場中佔最大佔有率。

根據國家/地區，歐洲生物程序技術市場分為英國、德國、法國、義大利、西班牙和歐洲其他地區。 2023年，德國市場在歐洲生物製程技術市場中佔有最大佔有率。

生物製藥動力股份有限公司；康寧公司；丹納赫公司；艾本德公司；龍沙集團股份公司；默克公司；雷普利根公司；賽多利斯公司；斯塔姆生物技術公司；和 Thermo Fisher Scientific Inc 是歐洲生物製程技術市場的領先公司。

Advanced bioprocess technologies bridge R&D with production. Several players are introducing a wide range of new bioprocessing technologies in the market. On December 4, 2020, IDBS (a provider of software informatics solutions for the biotech and pharmaceutical industries) announced the launch of Polar. Polar creates a new product category called BioPharma Lifecycle Management (BPLM) to streamline drug development and production in biopharma research. Polar is designed and deployed to rapidly solve challenges associated with workflow, process quality, collaboration, and data analysis that have plagued the existing software solutions, including laboratory information management system (LIMS) and electronic laboratory notebook (ELN). As a result, there will be less human errors and an improvement in overall accuracy. It will reduce manual data processing and transcription, leading to fewer human errors and enhanced overall accuracy. It also has extensive search features that make it easier for users to locate what they are searching for, preventing the need for pointless duplication of effort.

METTLER TOLEDO's Dynochem Biologics is a purpose-built simulation software that supports upstream and downstream unit activities in bioprocessing at any scale. Bioprocess engineers and scientists use the software to choose appropriate process operating parameters and establish scales equivalency. Utilities enable quick evaluation of equipment performance with minimal data, whereas more potent models leverage the existing data streams for process characterization. Initial projects can be completed quickly with the help of responsive application expertise, rich training resources, and a model library that is already built. Peptides, mAbs, vaccinations, and viral vectors are a few examples of the many applications.

Merck's new BioContinuum Platform advances biotherapeutic drug manufacturing through improved efficiency, simplified plant operations, and greater quality and consistency. In addition, Merck's Pellicon Single-Pass Tangential Flow Filtration aid in intensifying operations associated with the purification of therapeutic proteins. Thus, the introduction of various new-age bioprocess technologies is likely to provide lucrative opportunities for the market growth during the forecast period.

Europe Bioprocess Technology Market Overview

According to Germany Trade & Invest, the country is the second largest exporter of medicinal products and ranks among the top pharmaceutical producers across the world. Owing to the rising demand for personalized medicine, Germany has also evolved into one of the main suppliers of novel biopharmaceuticals. Biologics hold a considerable share of the pharmaceutical market in Germany due to their high therapeutic potential. According to a report by Germany Trade & Invest (GTAI) from 2015 to 2019, the biologics market grew by 11.6 % on average annually (more than twice the growth of the overall pharma market). The total revenue of biopharmaceuticals in Germany was US$ 13.96 billion in 2019, equivalent to more than a quarter of the pharmaceutical market. Germany has a major European pharmaceutical market and is the fourth largest across the world. In 2019, sales in the pharmaceutical industry in Germany increased by 5.7 %, from 2018, reaching US$ 51.01 billion (ex-manufacturer prices). More than 500 pharmaceutical companies are located in Germany. SMEs are the backbone of the economic sector, with around 90% of drug manufacturers having less than 500 employees. Thus, the growing pharmaceutical market in Europe will propel the use of bioprocess technology as biotechnology helps the pharmaceutical companies develop new products, processes, methods, and services and improve existing ones.

Europe Bioprocess Technology Market Revenue and Forecast to 2028 (US$ Million)

Europe Bioprocess Technology Market Segmentation

The Europe bioprocess technology market is segmented into type, modality, end user, and country.

Based on type, the Europe bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, and consumables & accessories, and others. In 2023, the consumables & accessories segment registered the largest share in the Europe bioprocess technology market.

Based on modality, the Europe bioprocess technology market is bifurcated into single use and multiple use. In 2023, the single use segment registered a larger share in the Europe bioprocess technology market.

Based on end user, the Europe bioprocess technology market is segmented into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. In 2023, the biopharmaceutical companies segment registered the largest share in the Europe bioprocess technology market.

Based on country, the Europe bioprocess technology market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. In 2023, Germany segment registered a largest share in the Europe bioprocess technology market.

BioPharma Dynamics Ltd; Corning Inc; Danaher Corp; Eppendorf SE; Lonza Group AG; Merck KGaA; Repligen Corp; Sartorius AG; STAMM Biotech; and Thermo Fisher Scientific Inc are the leading companies operating in the Europe bioprocess technology market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe bioprocess technology market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe bioprocess technology market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the bioprocess technology market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Europe Bioprocess Technology Market - by Type
- 1.3.2 Europe Bioprocess Technology Market - by Modality
- 1.3.3 Europe Bioprocess Technology Market - by End User
- 1.3.4 Europe Bioprocess Technology Market - by Country

2. Europe Bioprocess Technology Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Bioprocess Technology Market - Market Landscape

4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert's Opinion

5. Europe Bioprocess Technology Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Growing R&D Spendings to Introduce New Drug Compounds
- 5.1.2 Increasing Prevalence of Chronic Diseases
5.2 Market Restraints
- 5.2.1 Stringent Regulatory Policies
5.3 Market Opportunities
- 5.3.1 Introducing Advanced Bioprocess Technologies
5.4 Future Trends
- 5.4.1 Emergence of Automated Real?Time Flow Cytometry (ART?FCM)
5.5 Impact Analysis

6. Bioprocess Technology Market - Europe Analysis

6.1 Europe Bioprocess Technology Market Revenue Forecast and Analysis

7. Europe Bioprocess Technology Market - Revenue and Forecast to 2028 - by Type

7.1 Overview
7.2 Europe Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
7.3 Cell Culture Media Bioprocess
- 7.3.1 Overview
- 7.3.2 Cell Culture Media Bioprocess: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Chromatography Bioprocess
- 7.4.1 Overview
- 7.4.2 Chromatography Bioprocess: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Consumables & Accessories
- 7.5.1 Overview
- 7.5.2 Consumables & Accessories: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

8. Europe Bioprocess Technology Market Analysis and Forecasts to 2028 - by Modality

8.1 Overview
8.2 Europe Bioprocess Technology Market, by Modality 2022 & 2028 (%)
8.3 Single Use
- 8.3.1 Overview
- 8.3.2 Single Use: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Multiple Use
- 8.4.1 Overview
- 8.4.2 Multiple Use: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

9. Europe Bioprocess Technology Market - Revenue and Forecast to 2028 - by End User

9.1 Overview
9.2 Europe Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
9.3 Academic & Medical Institutions
- 9.3.1 Overview
- 9.3.2 Academic & Medical Institutions: Europe Bioprocess Technology Market - Revenue and Forecast to 2028(US$ Million)
9.4 Biopharmaceutical Companies
- 9.4.1 Overview
- 9.4.2 Biopharmaceutical Companies: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Research Laboratories
- 9.5.1 Overview
- 9.5.2 Research Laboratories: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

10. Europe Bioprocess Technology Market - Revenue and Forecast to 2028 - Country Analysis

10.1 Overview
- 10.1.1 Europe: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
  - 10.1.1.1 Germany: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 Germany: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.3 Germany: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    - 10.1.1.1.4 Germany: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    - 10.1.1.1.5 Germany: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  - 10.1.1.2 UK: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 UK: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.3 UK: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    - 10.1.1.2.4 UK: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    - 10.1.1.2.5 UK: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  - 10.1.1.3 France: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 France: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.3 France: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    - 10.1.1.3.4 France: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    - 10.1.1.3.5 France: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  - 10.1.1.4 Italy: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Italy: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.4.3 Italy: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    - 10.1.1.4.4 Italy: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    - 10.1.1.4.5 Italy: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  - 10.1.1.5 Spain: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 Spain: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.5.3 Spain: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    - 10.1.1.5.4 Spain: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    - 10.1.1.5.5 Spain: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  - 10.1.1.6 Rest of Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 Rest of Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.6.3 Rest of Europe: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    - 10.1.1.6.4 Rest of Europe: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    - 10.1.1.6.5 Rest of Europe: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)

11. Europe Bioprocess Technology Market - Industry Landscape

11.1 Overview
11.2 Organic Growth Strategies
- 11.2.1 Overview
11.3 Inorganic Growth Strategies
- 11.3.1 Overview

12. Company Profiles

12.1 Merck KGaA
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Sartorius AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Thermo Fisher Scientific Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Corning Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Lonza Group AG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Eppendorf SE
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Repligen Corp
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Danaher Corp
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 BioPharma Dynamics Ltd
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Europe Bioprocess Technology Market, Revenue and Forecast, 2020-2028 (US$ Million)
Table 2. Germany Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 5. UK Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 6. UK Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 7. UK Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 8. France Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 9. France Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 10. France Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 11. Italy Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 12. Italy Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 13. Italy Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 14. Spain Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 15. Spain Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 16. Spain Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Europe Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Europe Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of Europe Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 20. Recent Organic Growth Strategies in Bioprocess Technology Market
Table 21. Recent Inorganic Growth Strategies in the Europe bioprocess technology market
Table 22. Glossary of Terms

List Of Figures

Figure 1. Europe Bioprocess Technology Market Segmentation
Figure 2. Europe Bioprocess Technology Market, by Country
Figure 3. Europe Bioprocess Technology Market Overview
Figure 4. Others Segment Held Largest Share of Type Segment in Europe Bioprocess Technology Market
Figure 5. UK Expected to Show Remarkable Growth During Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Experts' Opinion
Figure 8. Europe Bioprocess Technology Market Impact and Analysis
Figure 9. Europe Bioprocess Technology Market - Revenue Forecast and Analysis - 2020-2028
Figure 10. Europe Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
Figure 11. Cell Culture Media Bioprocess: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Chromatographic Bioprocess: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Consumables & Accessories: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Others: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Europe Bioprocess Technology Market, by Modality 2022 & 2028 (%)
Figure 16. Single Use: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Multiple Use: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
Figure 19. Academic & Medical Institutions: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Biopharmaceutical Companies: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Research Laboratories: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Europe: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. Europe: Bioprocess Technology Market, by Country, 2022& 2028 (%)
Figure 25. Germany: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. UK: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. France: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Italy: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Spain: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Rest of Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)